Home
About Us
Products & Services
Market Info
Market Analysis
IPO
Corporate Actions
Other Markets
Currency
Company Information
Derivative
Mutual Fund
News
Contact Us
Open Account Online
Home
About Us
Products & Services
Charting
Contact Us
Board Meetings
Market
/
Corporate Action
/
Board Meetings
Easy Menu
Mutual Fund
Fund Profile
Daily Nav
Dividend Details
Scheme Profile
Historical NAV
MF News
MF Activities
Top 10 Holdings
New Fund Offer
Corporate Actions
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Mergers
DeMergers
Change Of Name
Split Of Face Value
Equity
Top Gainer
Top Loser
Value
Volume
52 Weeks High / Low
Advance and Decline
New High / New Low
Live Indices
Index Movers
Beta Stockwise
Only Buyers/Sellers
Bulk Deals
Block Deals
Out / Under Performers
Index Constituents
Unusual Volume
Historical Returns
Exchange Holidays
IPO
ForthComing IPO
Open IPO
Close IPO
New Listing
New Issue Monitor
Basis Of Allotment
Best Performers
Draft Prospectus
Know IPO's/FAQ's
Other Markets
ADR Price
World Indices
Skindia GDR
Derivatives
Derivatives
Futures
Options
Easy Menu
Main Menu
About Us
Products & Services
Market
Branches
Contact Us
Open Demat Account
Market
Equity
IPO
Derivatives
Corporate Actions
Mutual Funds
Other Market
Currency
News
Market
Equity
Daily Market Trackers
Top Gainers
Announcements
|
Book Closure
|
Board Meetings
|
Bonus Issues
|
Rights Issues
|
Delisted Shares
|
Market Turnover
|
Mergers
|
DeMergers
|
Change Of Name
|
Split Of Face Value
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Mergers
DeMergers
Change Of Name
Split Of Face Value
BSE Code
Company
Date
Purpose
500878
CEAT
14-Jun-2025
Ceat Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2025 inter alia to consider and approve Fund Raising Ceat Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2025 ,inter alia, to consider and approve In continuation to our letter dated June 5 2025 regarding meeting of the Finance and Banking Committee of Board of Directors scheduled on June 10 2025 to consider and approve issuance of Non-Convertible Debentures on a private placement basis, not exceeding Rs. 500 crores this is to inform you that the said agenda item has been deferred to subsequent meeting of the Committee scheduled to be held on June 14, 2025. (As Per BSE Announcement Dated on: 10.06.2025)
514360
K&R Rail Engine.
14-Jun-2025
K&R Rail Engineering Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve 1. Audited financial results for the quarter and year ended 31.03.2025. 2. Audit Report for quarter and year ended 31.03.2025. 3. Any other business with the permission of the Chair. The Board Meeting to be held on 05/06/2025 has been revised to 05/06/2025 The Board Meeting to be held on 30/05/2025 has been revised to 05/06/2025 (As per BSE Announcement Dated on 30/05/2025) The Board Meeting to be held on 05/06/2025 has been revised to 14/06/2025 The Board Meeting to be held on 05/06/2025 has been revised to 14/06/2025 (As per BSE Announcement Dated on 04/06/2025)
519602
Kellton Tech
14-Jun-2025
Kellton Tech Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/06/2025 ,inter alia, to consider and approve raising of funds by issuance of equity shares /warrants / and any other equity linked securities along with Alteration of the share Capital of the Company by sub-division/ split of existing Equity Shares of face value of Rs. 5/- Each
524394
Vimta Labs
14-Jun-2025
Vimta Labs Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2025 inter alia to consider and approve Intimation of Board of Directors Meeting.
526125
BN Holdings
14-Jun-2025
BN Holdings Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2025 inter alia to consider and approve to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31 2025 along with the Audit Report of the Auditors for the corresponding period.
Prev
1
2
Close